Morgan Stanley
GUTS icon

Morgan Stanley’s Fractyl Health GUTS Stock Holding History

Morgan Stanley’s Portfolio GUTS Stock Details GUTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$339K Sell
426,504
-69,397
-14% -$49.4K ﹤0.01% 5725
2026
Q1 		$227K Sell
495,901
-160,581
-24% -$148K ﹤0.01% 5820
2025
Q4 		$1.44M Buy
656,482
+226,251
+53% +$364K ﹤0.01% 4998
2025
Q3 		$684K Buy
430,231
+273,341
+174% +$355K ﹤0.01% 5354
2025
Q2 		$254K Sell
156,890
-3,149
-2% -$5.09K ﹤0.01% 5757
2025
Q1 		$190K Sell
160,039
-110,786
-41% -$177K ﹤0.01% 5748
2024
Q4 		$558K Buy
270,825
+103,549
+62% +$241K ﹤0.01% 5375
2024
Q3 		$423K Buy
167,276
+94,312
+129% +$308K ﹤0.01% 5478
2024
Q2 		$312K Sell
72,964
-205,576
-74% -$1.32M ﹤0.01% 5492
2024
Q1 		$2.06M Buy
+278,540
New +$2.35M ﹤0.01% 4551

Other funds holding GUTS

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
CCM
Catalio Capital Management New York $532M AUM 171.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $47.2M AUM 32.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley's GUTS Position: Q2 2026 in Review

Morgan Stanley reduced its Fractyl Health (GUTS) stake by 14% in Q2 2026, selling an estimated $49.4K and leaving 426,504 shares worth $339K. The position accounts for ﹤0.01% of the portfolio, ranked #5725.

Morgan Stanley first reported a position in GUTS in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.06M in Q1 2024. 77 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

  • Morgan Stanley held 426,504 shares of Fractyl Health worth $339K as of Q2 2026.
  • Morgan Stanley sold 69,397 Fractyl Health shares in Q2 2026, an estimated $49.4K.
  • Fractyl Health made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #5725 holding.
  • Morgan Stanley first reported a position in Fractyl Health in Q1 2024 and has held it in 10 quarters since.
  • Morgan Stanley's Fractyl Health position peaked at $2.06M in Q1 2024.
  • 77 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.